Biotechnology • Inflammatory
Bambusa Therapeutics is a biotechnology company developing transformative treatments for inflammatory and immunological conditions.
Mucosal Protection • Intranasal Antibody
Leyden Labs develops non-vaccine intranasal antibody treatments to protect against respiratory viruses like influenza and coronaviruses.
Genetic medicines • ALIGATER™ platform
Coave Therapeutics develops genetic medicines using their ALIGATER™ platform to enhance treatment for CNS, neuromuscular, and eye diseases.
Biotechnology • Drug Discovery
Tasca Therapeutics is a biotechnology company focused on developing small molecule inhibitors for oncology using a unique drug discovery platform.
Neuropsychiatric • Medicines
Seaport Therapeutics develops neuropsychiatric medicines using its Glyph technology platform to enhance oral bioavailability and reduce side effects, with a focus on treating depression, anxiety, and other disorders.
Biopharmaceutical • RNAi
City Therapeutics is a biopharmaceutical company focused on developing RNA interference-based medicines using engineered small interfering RNAs to target a broad range of diseases.
Biotech • Antibody treatments
Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.
Precision Oncology • Machine Learning
Engine Biosciences uses machine learning and high-throughput biology to develop precision oncology medicines, and with their recent funding, they plan to advance their biomarker and target discoveries toward the clinic through internal development, collaborations, and partnerships.
Biotech • Antibody treatments
Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.